NO784382L - Fremgangsmaate for fremstilling av tiazoldin-derivater - Google Patents

Fremgangsmaate for fremstilling av tiazoldin-derivater

Info

Publication number
NO784382L
NO784382L NO784382A NO784382A NO784382L NO 784382 L NO784382 L NO 784382L NO 784382 A NO784382 A NO 784382A NO 784382 A NO784382 A NO 784382A NO 784382 L NO784382 L NO 784382L
Authority
NO
Norway
Prior art keywords
tiazoldin
derivatives
procedure
preparation
tiazoldin derivatives
Prior art date
Application number
NO784382A
Other languages
English (en)
Other versions
NO148454B (no
NO148454C (no
Inventor
Dennis Claude Bigg
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7739559A external-priority patent/FR2413381A1/fr
Priority claimed from FR7833244A external-priority patent/FR2442232A2/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO784382L publication Critical patent/NO784382L/no
Publication of NO148454B publication Critical patent/NO148454B/no
Publication of NO148454C publication Critical patent/NO148454C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO784382A 1977-12-29 1978-12-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater NO148454C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7739559A FR2413381A1 (fr) 1977-12-29 1977-12-29 Derives de thiazolidinedione et leur application en therapeutique
FR7833244A FR2442232A2 (fr) 1978-11-24 1978-11-24 Derives de thiazolidinedione-2,4 et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO784382L true NO784382L (no) 1979-07-02
NO148454B NO148454B (no) 1983-07-04
NO148454C NO148454C (no) 1983-10-12

Family

ID=26220372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO784382A NO148454C (no) 1977-12-29 1978-12-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater

Country Status (17)

Country Link
US (1) US4349683A (no)
EP (1) EP0002978B1 (no)
JP (1) JPS6011908B2 (no)
AR (1) AR223160A1 (no)
AT (1) AT370098B (no)
AU (1) AU517221B2 (no)
CA (1) CA1107740A (no)
DE (1) DE2862059D1 (no)
DK (1) DK149429C (no)
ES (1) ES476408A1 (no)
FI (1) FI68819C (no)
GR (1) GR65312B (no)
IE (1) IE47902B1 (no)
IL (1) IL56304A (no)
NO (1) NO148454C (no)
NZ (1) NZ189300A (no)
PT (1) PT68991A (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPH0750560B2 (ja) * 1981-05-09 1995-05-31 ヤマハ株式会社 ディジタル集積回路装置
US4456756A (en) * 1981-08-03 1984-06-26 Mead Johnson & Company Spirothiazolidinyl piperazine derivatives
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
EP0715853A1 (en) * 1991-01-10 1996-06-12 Transcend Therapeutics, Inc. Use of glutathione esters for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
KR20150068829A (ko) * 2013-12-12 2015-06-22 삼성전자주식회사 알킬 암모늄염 화합물을 포함하는 유도 용질

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1435004A (fr) * 1965-02-04 1966-04-15 Sobio Lab Dérivés de thiazolidine-dione-2, 4- et procédé de préparation

Also Published As

Publication number Publication date
AT370098B (de) 1983-02-25
AU517221B2 (en) 1981-07-16
DK149429C (da) 1987-03-09
DK582578A (da) 1979-06-30
DK149429B (da) 1986-06-09
NO148454B (no) 1983-07-04
DE2862059D1 (en) 1982-11-11
FI68819B (fi) 1985-07-31
ES476408A1 (es) 1979-04-01
IE47902B1 (en) 1984-07-25
ATA936678A (de) 1982-07-15
NZ189300A (en) 1980-05-27
JPS6011908B2 (ja) 1985-03-28
FI68819C (fi) 1985-11-11
US4349683A (en) 1982-09-14
CA1107740A (en) 1981-08-25
EP0002978A2 (fr) 1979-07-11
EP0002978A3 (en) 1979-07-25
AR223160A1 (es) 1981-07-31
AU4296178A (en) 1979-07-05
NO148454C (no) 1983-10-12
PT68991A (fr) 1979-01-01
IL56304A0 (en) 1979-03-12
IE782561L (en) 1979-06-29
GR65312B (en) 1980-08-02
JPS5498758A (en) 1979-08-03
EP0002978B1 (fr) 1982-10-06
FI783995A (fi) 1979-06-30
IL56304A (en) 1982-02-28

Similar Documents

Publication Publication Date Title
SE7811689L (sv) Forfarande for framstellning av maytansinoider
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO151895C (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
SE7803743L (sv) Forfarande for framstellning av diazepinderivat
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
NO791139L (no) Fremgangsmaate for fremstilling av lysergolderivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
AR211570A1 (es) Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo
SE7800933L (sv) Forfarande for framstellning av 3-metylpyridin
SE7805676L (sv) Nytt forfarande for framstellning av alkaloider av leurosintypen
SE434266B (sv) Forfarande for framstellning av prostacyklinderivat
NO780390L (no) Fremgangsmaate for fremstilling av oleandomycin-derivater
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO781928L (no) Fremgangsmaate til fremstilling av guanidinderivater
NO802435L (no) Fremgangsmaate til fremstilling av tetrahydrokinolinderivater
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
NO792659L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
SE7805324L (sv) Forfarande for framstellning av 3-bromftalid
NO771576L (no) Fremgangsmaate for fremstilling av di-n-propylacetonitril
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
NO149774C (no) Fremgangsmaate for fremstilling av et azetidinon